California Resources (CRC) files Form 144 to sell 279,737 shares

Rhea-AI Filing Summary

California Resources Corporation's Form 144 notifies the market of a proposed sale of 279,737 shares of common stock, with an aggregate market value of $13,391,010, to be sold on or about 08/12/2025 on the NYSE. The filing lists 83,679,985 shares outstanding, so the planned sale represents approximately 0.334% of outstanding common stock.

The shares were acquired on 07/01/2024 as merger consideration in a "merger with and into issuer" transaction and were paid for on that date. The filing reports Nothing to Report for securities sold in the past three months. The filing includes the standard representation that the reporting person is not aware of undisclosed material adverse information.

Positive

• Transparent disclosure of a proposed insider sale of 279,737 shares valued at $13.39M in accordance with Form 144 requirements
• No reported sales in the past three months, indicating this filing documents a single planned sale rather than ongoing disposals

Negative

• Insider intends to sell shares worth $13.39M, which could increase supply on the planned sale date
• No 10b5-1 adoption date or trading-plan date is provided in the filing, so planned sale timing and instructions are not documented here

Insights

Financial Analyst

TL;DR: Routine insider sale disclosure; size is small relative to outstanding shares and unlikely to be materially market-moving.

The Form 144 reports a planned disposition of 279,737 shares valued at $13.39M, representing roughly 0.334% of the company's 83,679,985 outstanding shares. The shares were received as merger consideration on 07/01/2024. There are no reported sales in the past three months, suggesting this is a discrete liquidity event rather than continued selling pressure. From a market-impact perspective, the disclosed size is modest; the filing itself is a compliance disclosure rather than an operational development.

Corporate Governance Expert

TL;DR: Disclosure meets Form 144 requirements; absence of a declared 10b5-1 adoption date is notable but not uncommon.

The filing identifies the broker as Citigroup Global Markets Inc. and shows the securities were acquired via merger consideration. The Remarks section contains the standard attestation about lack of undisclosed material adverse information. The filing does not provide a trading-plan adoption date or related instruction date, so no explicit 10b5-1 plan is documented here. Overall, the document reflects standard insider-sale disclosure and compliance with Rule 144 notification requirements.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Citigroup Global Markets Inc. 388 GREENWICH STREET New York NY 10013	279737	13391010.00	83679985	08/12/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	07/01/2024	Merger with and into Issuer	Issuer			279737	07/01/2024	Merger Consideration

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does CRC's Form 144 disclose?

The filing discloses a proposed sale of 279,737 CRC common shares with an aggregate market value of $13,391,010, to be sold on or about 08/12/2025 on the NYSE.

When and how were the shares being sold acquired?

The shares were acquired on 07/01/2024 as merger consideration in a "merger with and into issuer" transaction, with payment dated 07/01/2024.

How large is the proposed sale relative to CRC's outstanding shares?

The filing lists 83,679,985 shares outstanding, so 279,737 shares represent approximately 0.334% of outstanding common stock.

Has the reporting person sold CRC securities in the last three months?

The filing states Nothing to Report for securities sold during the past three months.

Who is the broker handling the proposed sale?

The broker named in the filing is Citigroup Global Markets Inc. located at 388 Greenwich Street, New York, NY 10013.

Does the Form 144 indicate a 10b5-1 trading plan?

No adoption date or trading-plan instruction date is provided in this filing.